Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agents for treating human immunodeficiency virus infection

E P Acosta1, C V Fletcher

  • 1Department of Pharmacy Practice, College of Pharmacy, University of Minnesota, Minneapolis 55455.

American Journal of Hospital Pharmacy
|September 15, 1994
PubMed
Summary

This review covers the human immunodeficiency virus (HIV) replication cycle and current/investigational drugs. While progress is made, more potent HIV therapies are needed, emphasizing optimized use of existing agents and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
Same author

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

The Journal of antimicrobial chemotherapy·2020
Same author

Pharmacokinetics of tenofovir during pregnancy and postpartum.

HIV medicine·2015
Same author

Helicase-primase as a target of new therapies for herpes simplex virus infections.

Clinical pharmacology and therapeutics·2015
Same author

The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.

Clinical pharmacology and therapeutics·2014
Same author

Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo.

Clinical pharmacology and therapeutics·2010

Area of Science:

  • Virology
  • Pharmacology

Background:

  • The human immunodeficiency virus (HIV) replicates through a cycle involving viral entry, reverse transcription, integration, transcription, translation, and budding.
  • Drug development targets specific stages of the HIV replicative cycle.

Purpose of the Study:

  • To review the HIV replicative cycle.
  • To discuss currently used and investigational antiviral agents.
  • To highlight the need for more effective HIV therapies.

Main Methods:

  • Literature review of HIV replication mechanisms.
  • Categorization of antiviral agents based on their mechanism of action.
  • Summary of approved and investigational HIV drugs.

Main Results:

Related Experiment Videos

  • Identified key targets in the HIV replicative cycle for drug intervention: binding/entry, reverse transcriptase, transcription/translation, and maturation/budding.
  • Listed approved drugs (zidovudine, didanosine, zalcitabine, stavudine) and investigational agents.
  • Noted that zidovudine monotherapy is the current first-choice treatment.

Conclusions:

  • Significant progress has been made in developing therapies for HIV infection.
  • There is an urgent need for more selective and potent antiviral drugs.
  • Optimizing current treatments, continued research, and public education are crucial for managing HIV.